Biktarvy

Biktarvy is a combination medication used in the treatment of HIV-1 infection. It contains Emtricitabine, Tenofovir Alafenamide, and Bictegravir, offering a convenient once-daily oral therapy. This antiretroviral drug helps manage HIV by reducing the amount of virus in the body.

Biktarvy is primarily used for the treatment of HIV-1 infection in adults and children weighing at least 25 kg. This medication is a fixed-dose combination of Emtricitabine, Tenofovir Alafenamide, and Bictegravir, which work together to inhibit the replication of the HIV virus. It is often prescribed as part of a comprehensive HIV treatment plan to reduce viral load and improve immune function.

Common effects of Biktarvy may include nausea, diarrhea, and headache. Some individuals might experience changes in liver function or bone density. It is important to monitor for any unusual symptoms and consult a healthcare provider if concerns arise.

Biktarvy should be handled with care, especially for individuals with kidney or liver problems. Regular monitoring of kidney function and bone density is recommended. It is crucial to follow the prescribed dosage and not to share this medication with others.

Biktarvy may interact with other medications, including certain antacids, laxatives, and other HIV drugs. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Alcohol and certain supplements may also affect the efficacy of Biktarvy.